others 6 7 fail to support this conclusion. The prevalence of this phenotype in a population Background -A study was undertaken to clarify whether the Pi SZ phenotype of the of patients with COPD compared with that found in newborn infants from the same geoprotease inhibitor system predisposes to chronic obstructive pulmonary disease graphical area was investigated with the aim of clarifying whether the PI SZ phenotype pre-(COPD). Methods -The prevalence of PI Z and PI disposes to the development of chronic respiratory disease. SZ deficient phenotypes was investigated in a population of 702 patients with COPD followed up at the Chest Unit of a tertiary hospital and in 15 400 newborn infants Methods from the same geographical area. In-  dividuals with deficiency were detected A patient was considered as eligible if he or by screening of dried blood spots on filter she had a diagnosis of COPD (chronic bronpaper using a comparative electro-chitis and emphysema) and was receiving medimmunodiffusion technique for 1 -anti-ical care at the Chest Unit of Valdecilla Hospital trypsin and transferrin. The serum in Cantabria (Spain) in 1993. Inclusion criteria phenotype was confirmed by means of iso-were diagnosis of symptomatic COPD, forced electrofocusing on polyacrylamide gel.
physema.
1 Over 75 variants of the PI system hours. The plates were then stained with Spain have been recognised, some of which may pro-Coomassie Blue. duce a clinically significant reduction in levels The result of the electrophoresis cor- in a pilot study of 102 newborn infants and 50 COPD five years previously. After his inclusion in the study population he was diagnosed as patients with COPD that no PI SZ individual was identified above this point.
having extrinsic allergic alveolitis after exposure to avian antigens. In those individuals with suspect samples on immunodiffusion, a blood sample was taken With respect to the neonate population, four of the eight PI Z individuals detected presented and the serum phenotype was determined by isoelectrofocusing at pH 4.2-4.9 on poly-with hepatomegaly; one child developed cirrhosis and portal hypertension, while the other acrylamide gel 9 and the 1 -antitrypsin serum level was determined by immunonephelometry three presented at one year with persistent hepatomegaly and raised hepatocellular en-(Beckman).
zymes. The remaining four PI Z individuals were asymptomatic with no biochemical changes. The 24 PI SZ neonates were also   Case histories were taken from all PI Z and PI asymptomatic, and only one presented with slightly raised hepatocellular enzymes. SZ individuals who underwent physical examination and analysis of basic haematological and biochemical parameters including hepatic enzymes. PI Z and PI SZ individuals from the Discussion Although the association between the Pi Z population with COPD also underwent chest radiography, computed axial tomographic phenotype and the development of pulmonary emphysema is well known, it is at present (CT) scanning, spirometric and pulmonary function tests.
impossible to predict the natural history of a PI Z individual. The number of PI Z individuals with emphysema is well below the total number of these individuals in the population 10 and, in   The comparison of prevalences was carried out most screening studies carried out on the general population, the PI Z individuals detected using the Fisher exact test.
present with low levels of respiratory disease.
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This lack of knowledge is more marked when we consider PI SZ individuals. It is unclear Results There was a predominance of men (79.8%), whether this phenotype involves a risk of developing pulmonary emphysema. Further of smokers (80.5%), and of those aged 40-60 years (57.4%) in the study population. Mean understanding on this matter is important as the number of PI SZ individuals in the population (SD) FEV 1 was 1.14 (0.32) l (56 (17)% predicted). FEV 1 /FVC was 54 (14)%. is 2-3 times greater than that of the PI Z phenotype. Of the 702 patients with COPD subjected to screening, 17 (2.4%) were found to have an
In the controversy about the pulmonary involvement of this phenotype, an initial study 1 -antitrypsin/transferrin ratio of less than 0.65. Phenotype determination showed that six of described the association of PI SZ with pulmonary emphysema 4 which resulted in PI SZ these were PI Z and one was PI SZ; the rest consisted of five PI MZ, three PI MS, and two being considered a risk phenotype. However, the number of PI SZ individuals recorded with PI MM. In the neonate population 58 (3.8/ 1000) suspect samples were detected of which emphysema is clearly lower than the number of PI Z individuals despite being a more frequent eight were PI Z and 24 PI SZ; the remaining suspect samples consisted of one PI FS, three phenotype, and this suggests that the SZ phenotype does not involve any special risk for the PI SS, five PI MZ, five PI MS, six PI MM, and six infants whose phenotype we were unable to development of respiratory disease. 6 The number of studies on the prevalence of determine. The number of PI Z individuals found in the group of patients with COPD was PI Z and PI SZ individuals in COPD populations is small. Only two studies have analysed significantly higher (p <0.001) than that found in the neonates. The difference was not sig-populations of over 500. Lieberman 7 found a prevalence of PI Z of 1.9% in 965 patients with nificant for PI SZ (p = 0.975).
The six COPD patients with PI Z presented COPD and reported no difference between these patients and normal individuals with rewith emphysema (table 1) . Four subjects were aged Ζ40. All presented with radiological and gard to the number with the PI SZ phenotype.
On the other hand, Bartman 5 found five PI Z CT findings compatible with emphysema. The PI SZ individual detected was a 60 year old and 18 PI SZ individuals in 526 patients with COPD compared with two PI Z and one PI man with clinical and spirometric criteria of 
